Mirabegron

Common brands: Myrbetriq, Mirabgeorn, Vitamin D, Acid Reducer, Tylenol Extra Strength

Top reporter: Astellas Pharma Us, Inc.

beta3-Adrenergic Agonist [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Corticosteroid [EPC]Provitamin D2 Compound [EPC]Vitamin C [EPC]
37,628
Total Reports
13,844
Serious Reports
3,028
Death Reports
30
Reported Reactions
Death Report Ratio: High (8.05%)

Patient Demographics

Male
11,690
Female
23,391

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Mirabegron.

# Reaction Reports % of Total
1 DRUG INEFFECTIVE 5,806
11.6%
2 OFF LABEL USE 2,746
5.5%
3 FATIGUE 2,262
4.5%
4 HEADACHE 2,206
4.4%
5 DIZZINESS 2,168
4.4%
6 FALL 1,968
3.9%
7 DIARRHOEA 1,922
3.9%
8 PAIN 1,783
3.6%
9 NAUSEA 1,740
3.5%
10 INTENTIONAL PRODUCT MISUSE 1,529
3.1%
11 ASTHENIA 1,525
3.1%
12 HYPERTENSION 1,521
3.1%
13 BLOOD PRESSURE INCREASED 1,485
3.0%
14 ARTHRALGIA 1,433
2.9%
15 RASH 1,388
2.8%
16 DRY MOUTH 1,378
2.8%
17 CONFUSIONAL STATE 1,366
2.7%
18 DYSPNOEA 1,341
2.7%
19 CONDITION AGGRAVATED 1,331
2.7%
20 URINARY TRACT INFECTION 1,319
2.6%
21 CONSTIPATION 1,312
2.6%
22 VOMITING 1,232
2.5%
23 PERIPHERAL SWELLING 1,190
2.4%
24 ABDOMINAL PAIN UPPER 1,157
2.3%
25 MALAISE 1,137
2.3%
26 INSOMNIA 1,132
2.3%
27 HYPOAESTHESIA 1,128
2.3%
28 MEMORY IMPAIRMENT 1,124
2.3%
29 INTENTIONAL PRODUCT USE ISSUE 1,108
2.2%
30 NASOPHARYNGITIS 1,101
2.2%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.